Explore E-Briefings
E-briefings are published weekly and are listed below, with the most recent at the top. You may filter by topic and access dozens of additional articles using the page navigation below. Check back often to access new articles online or subscribe to have each new article delivered straight to your inbox weekly!
Former FDA Head Scott Gottlieb to Headline Upcoming Artificial Intelligence in Healthcare and Diagnostics Conference
Gottlieb will speak at two sessions during the AIHD Conference, which takes place May 10-11 in San Jose. Expect his focus to be on the state of AI in healthcare.
Cornell Researchers Have Discovered Precision Medicine Treatment That Overcomes Chemotherapy-Resistant Gastric Cancer
Researchers at Weill Cornell Medicine believe they have discovered the variant protein that causes taxane-resistant cancer cells to develop.
New Organoid Technology May Offer Hospitals Improved Precision Medicine Treatments for Prostate Cancer
By using organoids, “we can show that for a particular patient subset, for a particular drug, we can do better than the current selection criteria,” stated Else Driehuis, PhD.
University of Helsinki Researchers Find Functional Precision Medicine Offers Superior Approach to Leukemia Treatments
The approach combined deep molecular profiling with comprehensive drug sensitivity testing for patients where standard therapy alternatives had been exhausted.
Memorial Sloan Kettering Cancer Center Gains FDA Partial Recognition of its OncoKB Oncology Knowledge Database
A recently FDA-recognized somatic cancer database organizes tumor genomic profiling and cancer drugs into levels of clinical evidence that can be used by hospital and oncology leaders.
Mount Sinai Researchers Find Cancer Treatment Implications Based on Age-Dependent Cancer Genetics
Comprehensive assessment of young adult tumors across multiple cancer types reveals age-related cancer genetics that are important to treatment decisions.
Newly Discovered Imaging Biomarkers Enable Hospitals to Predict Patients’ Response to Antidepressant Therapy
UT Southwestern Medical Center research has discovered imaging biomarkers that can predict what response patients will have to antidepressant medications.
Precision Medicine Research for Pulmonary Fibrosis May Bring New Treatments Closer
Personalized treatments for idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (IDLs) step closer to reality as new study techniques and improved funding advance research.
Precision Medicine Study Shows Failed Cancer Medicine May Actually Be Effective for Aggressive Breast Cancers
Renewed interest in abandoned drugs for specific subsegments of certain healthcare populations could lead to new personalized treatments for cancer and other chronic diseases.
Genetic Sequencing Alone May Not Be Enough to Optimize Precision Medicine Treatment, Harvard and MIT Researchers Find
Researchers have found that cancer cells have different states in which different sets of genes are expressed, influencing what drugs will be effective for those cells given that specific point in time.